Company Details

Aptorum Therapeutics Limited

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications). The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through programs such as the systematic screening of existing approved drug molecules and microbiome-based research platform for treatments of metabolic diseases. In addition to the above main focus, the company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health and other disease areas. Aptorum also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.

Unit 232, Building 12W, No. 12 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong
+852 21176611
Dr. Angel Ng

The information provided on this page is for reference only. Please refer to the latest information published by the partner company.

Contact Us

For general enquiry, or questions about HKSTP’s services and support, please enter your email address and query here.